DAGGER Trademark

Trademark Overview


On Tuesday, November 22, 2022, a trademark application was filed for DAGGER with the United States Patent and Trademark Office. The USPTO has given the DAGGER trademark a serial number of 97688353. The federal status of this trademark filing is REGISTERED as of Tuesday, September 5, 2023. This trademark is owned by Allogene Therapeutics, Inc.. The DAGGER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; pharmaceutical and biological preparations for immunotherapy, namely, for use in improving immune evasion, improving cell expansion and potency, and/or reducing rejection by patient immune system
dagger

General Information


Serial Number97688353
Word MarkDAGGER
Filing DateTuesday, November 22, 2022
Status700 - REGISTERED
Status DateTuesday, September 5, 2023
Registration Number7159383
Registration DateTuesday, September 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; pharmaceutical and biological preparations for immunotherapy, namely, for use in improving immune evasion, improving cell expansion and potency, and/or reducing rejection by patient immune system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 25, 2022
Primary Code005
First Use Anywhere DateThursday, June 29, 2023
First Use In Commerce DateThursday, June 29, 2023

Trademark Owner History


Party NameAllogene Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 5, 2023REGISTERED-PRINCIPAL REGISTER
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 4, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 3, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 3, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, July 24, 2023USE AMENDMENT FILED
Thursday, August 3, 2023SOU EXTENSION 1 GRANTED
Monday, July 24, 2023SOU EXTENSION 1 FILED
Tuesday, August 1, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 24, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Friday, November 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 25, 2022NEW APPLICATION ENTERED